Zimmer Biomet Holdings Inc. and Monogram Technologies Inc., an orthopedic robotics company, have announced that they have ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Investing.com -- BiomX (NYSE: PHGE) Inc. (NYSE American:PHGE) stock surged 60% after the clinical-stage company announced it has successfully initiated patient dosing in its Phase 2b trial evaluating ...

The FDA has removed the REMS program requirements for embryofetal toxicity risk from all endothelin receptor antagonist medications.

The FDA published over 200 response letters sent as replies to drug and biological product applications in order to increase transparency.

GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults aged 18-49 who are at increased risk of contracting the ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop ...

Corcept Therapeutics has filed for U.S. Food and Drug Administration approval of its relacorilant drug candidate for the treatment of patients with platinum-resistant ovarian cancer.

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 670 against its upper ...

Investing.com -- Firefly Neuroscience Inc (NASDAQ: AIFF) stock rose 3% following the announcement of its ongoing collaboration with Heidelberg (ETR: HDDG) University Hospital on a study investigating ...

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...